Literature DB >> 14668459

Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis.

Sabine-Gisela Plötz1, Hans-Uwe Simon, Ulf Darsow, Dagmar Simon, Ekatherina Vassina, Shida Yousefi, Rüdiger Hein, Tim Smith, Heidrun Behrendt, Johannes Ring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14668459     DOI： 10.1056/NEJMoa031261

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  51 in total

Review 1.  Averting inflammation by targeting the cytokine environment.

Authors:  Manfred Kopf; Martin F Bachmann; Benjamin J Marsland
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

Review 2.  Cytokine and anti-cytokine therapy for asthma.

Authors:  Hans-Uwe Simon
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

Review 3.  Biologic therapies: what and when?

Authors:  Sarah L Johnston
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

Review 4.  Eosinophils and urticaria.

Authors:  Delphine Staumont-Sallé; David Dombrowicz; Monique Capron; Emmanuel Delaporte
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

Review 5.  Usefulness and optimization of mouse models of allergic airway disease.

Authors:  Fred D Finkelman; Marsha Wills-Karp
Journal:  J Allergy Clin Immunol       Date:  2008-03       Impact factor: 10.793

Review 6.  Biologic therapies targeting eosinophils: current status and future prospects.

Authors:  Fanny Legrand; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2015 Mar-Apr

7.  Murine lung eosinophil activation and chemokine production in allergic airway inflammation.

Authors:  C Edward Rose; Joanne A Lannigan; Paul Kim; James J Lee; Shu Man Fu; Sun-sang J Sung
Journal:  Cell Mol Immunol       Date:  2010-07-12       Impact factor: 11.530

Review 8.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

9.  Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome.

Authors:  Fei Li Kuang; Michael P Fay; JeanAnne Ware; Lauren Wetzler; Nicole Holland-Thomas; Thomas Brown; Hector Ortega; Jonathan Steinfeld; Paneez Khoury; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2018-05-08

Review 10.  Adult eosinophilic gastroenteritis and hypereosinophilic syndromes.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.